Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
United Kingdom
/
ETF market
/
1ARG
/
Analysis
LS ARK GENOMIC REVOLUTION TRACKER ETP
1ARG
London Stock Exchange
1ARG
London Stock Exchange
1ARG
London Stock Exchange
1ARG
London Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
News
Ideas
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
532.13 K
USD
Fund flows (1Y)
177.13 K
USD
Dividend yield (indicated)
—
Discount/Premium to NAV
3.7%
About LS ARK GENOMIC REVOLUTION TRACKER ETP
Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Leverage Shares
Expense ratio
0.35%
Home page
leverageshares.com
Inception date
Dec 14, 2021
Index tracked
No Underlying Index
Management style
Passive
ISIN
XS2399368062
The objective of the LS ARKG Genomic Tracker ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the Reference Asset),
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Vanilla
Weighting scheme
Fixed
Selection criteria
Fixed
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of December 19, 2024
Exposure type
Bonds, Cash & Other
ETF
Bonds, Cash & Other
100.00%
ETF
100.00%
Stock breakdown by region
100%
North America
100.00%
Latin America
0.00%
Europe
0.00%
Asia
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows